Psoriasis is a systemic disease

New non-allergenic, anti-inflammatory fragrance could be game changer for dry skin sufferers

New evidence shows that systemic inflammation in psoriasis can be treated orally with a non-living strain of a commensal microbe

New Research Reveals that Risky Sexual Behaviour and STIs are on the Rise Despite COVID-19 Pandemic

New analysis reveals ‘long-hauler’ COVID-19 patients with prolonged skin symptoms - Lessons from the International COVID-19 Dermatology Registry

Urban living decreases skin bacterial diversity and why is it a problem

Contact dermatitis: New allergens

Hidradenitis suppurativa

Moderate psoriasis: a journey towards patient-centred care

Emerging treatments for onychomycosis

Primay results on acne exposome: real life data

Safety and efficacy of the oral JAK3/TEC inhibitor PF-06651600 and the oral TYK2/JAK1 inhibitor PF-06700841 in a withdrawal/retreatment extension study in patients with alopecia areata

Highlights of the laser session at EADV 2019

International landscape of therapies in CTCL

Molecular resistance to targeted therapy, from bench to bedside

When instruments are not enough, clinical clues are needed